HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.

8th Edition of Cardiology World Conference

September 27-29, 2027 | London, UK

September 27 -29, 2027 | London, UK

Coronary Restenosis

Coronary Restenosis

Coronary restenosis is a medical phenomenon marked by the re-narrowing or blockage of coronary arteries subsequent to an initial medical intervention like angioplasty or the placement of a stent to address coronary artery disease. While these interventions initially succeed in restoring blood flow to the heart, the recurrence of symptoms, such as chest pain or angina, indicates the onset of restenosis. This condition is primarily attributed to the re-growth of tissue within the treated artery, referred to as neointimal hyperplasia, or the reappearance of atherosclerotic plaque. The development of coronary restenosis involves a complex interplay of factors, including patient-specific characteristics, procedural techniques employed during the initial intervention, and the types of devices used. Continuous efforts by researchers and clinicians are focused on devising strategies to mitigate the risk of restenosis. One such advancement includes the development of drug-eluting stents that release medication, aiming to inhibit excessive tissue growth in the treated arteries.

Committee Members
Speaker at Cardiology World Conference 2027 - Sekib Sokolovic

Sekib Sokolovic

ASA Hospital, Bosnia and Herzegowina
Speaker at Cardiology World Conference 2027 - James V Cireddu

James V Cireddu

Case Western University, United States
Speaker at Cardiology World Conference 2027 - Iris Panagiota Efthymiou

Iris Panagiota Efthymiou

Regent College London, United Kingdom

Submit your abstract Today

Whatsapp